The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory biomarker results from early investigation of PEGPH20 in combination with gemcitabine (Gem) in patients with pancreatic cancer (PDA).
 
Sunil R. Hingorani
Research Funding - Halozyme
 
William Proctor Harris
No Relationships to Disclose
 
Joseph Thaddeus Beck
Consulting or Advisory Role - Halozyme
 
Boris A. Berdov
No Relationships to Disclose
 
Stephanie Ann Wagner
No Relationships to Disclose
 
Eduard M. Pshevlotsky
Honoraria - Halozyme
 
Sergei Tjulandin
No Relationships to Disclose
 
Oleg Gladkov
No Relationships to Disclose
 
Randall F. Holcombe
No Relationships to Disclose
 
Ping Jiang
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
Honoraria - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme
 
Daniel C. Maneval
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
Honoraria - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme
 
Ronald I Korn
Employment - Imaging Endpoints
Leadership - Imaging Endpoints
 
Harold Michael Shepard
Employment - Halozyme
Leadership - Halozyme
Stock and Other Ownership Interests - Halozyme
Honoraria - Halozyme
Speakers' Bureau - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme
 
Craig E. Devoe
No Relationships to Disclose